Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07313384 · ClinicalTrials.gov registry record
Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy
A clinical trial of Obesity (Disorder) and Obesity Type 2 Diabetes Mellitus, sponsored by University of South Carolina.
- Recruiting
- Registry status
- 50
- Enrollment target
- 2
- Study locations
NCT07313384: Recruiting study of Obesity (Disorder) and Obesity Type 2 Diabetes Mellitus, sponsored by University of South Carolina.
NCT07313384 is a study of Obesity (Disorder) and Obesity Type 2 Diabetes Mellitus that is actively recruiting participants, run by University of South Carolina. The registered enrollment target is 50 participants, below the 104-participant average among 5 other Obesity (Disorder) trials with a reported enrollment target (52% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT07313384, a study of Obesity (Disorder) and Obesity Type 2 Diabetes Mellitus, is actively recruiting participants, sponsored by University of South Carolina.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 2
- Study locations
Study Summary
The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since these medications reduce food intake, it's important to ensure the diet is nutritious even with fewer calories to help with long-term weight control and health. Most research has looked at how the body responds to the medication and whether patients take it as prescribed, but not much is known about what patients actually experience, what they think they need, or how they could use additional support. Understanding patients' views can help create better lasting solutions. Note that this study does not provide free GLP-1 medication.
Primary Outcome
The Healthy Eating Index (HEI) is a scoring metric developed by the U.S. Department of Agriculture (USDA) and the NCI to assess how well a person's diet conforms to the Dietary Guidelines for Americans. It evaluates the consumption of 13 dietary components, including both adequacy (foods to increase) and moderation (foods to decrease). The scores range from 0 to 100. An ideal overall HEI score of 100 reflects that the set of foods aligns with key dietary recommendations and dietary patterns publ
Conditions Studied
Interventions
- DRUG GLP-1 Therapy
Study Locations (2)
South Carolina
- University South Carolina - Columbia
- Prisma Health Weight Management Institute - Greenville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2026-02-11 |
| Est. Completion | 2026-12-01 |
What NCT07313384 shows while recruiting
NCT07313384 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target, below the 104-participant average among 5 other Obesity (Disorder) trials with a reported enrollment target (52% lower).
The record links to 2 conditions, with Obesity (Disorder) appearing as the primary indexed condition, and to 1 intervention - of which GLP-1 Therapy is the first listed.
NCT07313384 reports a single indexed study location in South Carolina.
Frequently Asked Questions
What is clinical trial NCT07313384 about?
NCT07313384 is a clinical study titled "Dietary Insights and Nutrition Experiences in Adults on GLP-1 Therapy - A Study on Diet Quality Changes in Adults on GLP-1 Therapy". The DINE-GLP1 study aims to understand how people on GLP-1 therapy change their eating habits and what kind of dietary support they need. As more people use GLP-1 medications, there's not much guidance on what they should eat, mostly just focusing on managing symptoms and cutting calories. Since the...
What is the current status of trial NCT07313384?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2026-02-11. Estimated completion is 2026-12-01.
What conditions does trial NCT07313384 study?
This clinical trial studies the following conditions: Obesity (Disorder), Obesity Type 2 Diabetes Mellitus.
What interventions are being tested in trial NCT07313384?
The interventions under investigation include: GLP-1 Therapy (DRUG).
Who is sponsoring clinical trial NCT07313384?
This trial is sponsored by University of South Carolina, which has 157 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07313384 being conducted?
This trial has 2 study locations across South Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Obesity (Disorder)
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Optimizing Self-Monitoring Feedback Delivery for the Treatment of Overweight and Obesity
RECRUITING · NA
-
Effects of Glucagon-like Peptide-1 (GLP-1) Agonist in Neuro-reproductive Function in Obese Adolescent Females With Polycystic Ovary Syndrome (PCOS)
RECRUITING
-
The Epidemiology and Pathophysiology of Kidney Disease in HFpEF With Obesity
RECRUITING
-
Healthy Living Anson Study
RECRUITING · NA
-
Repeated Far Infrared Sauna Bathing in Adults With Obesity
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI